• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameexcimer laser system
Generic Nameexcimer laser system
messerschmittstr 1 + 3
munchen 80992
PMA NumberP990027
Supplement NumberS011
Date Received09/03/2008
Decision Date05/01/2009
Product Code
LZS[ Registered Establishments with LZS ]
Advisory Committee Ophthalmic
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the dynamic rotational eye tracker with iris recognition for use with the bausch & lomb technolas 217z zyoptix laser system for personalized visioncorrection. The device, as modified, will be marketed under the trade name technolas 217z zyoptix laser system for personalized vision correction and is indicated for:1) wavefront-guided laser assisted in-situ keratomileusis (lasik) treatments for the reduction orelimination of myopia with sphere up to -7. 00 d and cylinder up to -3. 00 d and mrse < = 7. 50 d atthe spectacle plane:reduction or elimination of myopia (nearsightedness) from -1. 00 d to -7. 00 d with less than -3. 00 d astigmatism;2) reduction or elimination of myopic astigmatism up to -12. 00 d mrse, with sphere between > -7. 00 d to -10. 99 d and cylinder between 0. 00 and < -3. 00 d; and 4) reduction or elimination of low-to-moderate naturally occurring hyperopia up to +4. 00 d mrse, with sphere between +1. 00 d to +4. 00 d with or without refractive astigmatism up to+2. 00 d at the spectacle plane.